Posted in | News | Nanomaterials | Nanoenergy

Nanocomposite Reverse Osmosis Membrane Provider Named Among Global Cleantech 100

NanoH2O, a global provider of reverse osmosis membranes for desalination, today announced it has been named in the prestigious 2010 Global Cleantech 100, produced by the Cleantech Group, providers of leading global market research, events and advisory services for the cleantech industry.

The list is produced as part of the Global Cleantech 100 program, run in collaboration with the Guardian News and Media and sponsored by Autodesk.

The Global Cleantech 100 is unique in as much as it highlights the most promising private clean technology companies from all around the world, those companies which are the most likely to make the most significant market impact over the next five to 10 years in the eyes of the world’s cleantech experts.

The answer is derived by the Cleantech Group, who draws on its own data and research, and combines it with the weighted qualitative judgments of both hundreds of cleantech industry insiders, and the viewpoints of a 60-strong, international expert panel. To qualify for the list, companies must be independent, for-profit, cleantech companies that are not listed on any major stock exchange.

4,616 nominations were received from 3,260 unique sources, providing a long list of 3,138 companies drawn from 50 countries. 218 companies were presented to the expert panel for final input. The end result was 100 companies from 14 countries.

The 60-strong expert panel is drawn from well-respected organizations in cleantech innovation from around the world, including leading investors such as Emerald Technology Ventures, Generation Investment Management, Kleiner Perkins Caulfield & Byers, New Enterprise Associates, SAM Private Equity, Sequoia Capital, and VantagePoint Venture Partners, and from a wide variety of corporations from many different industries, such as BASF, GE, Honeywell, IBM, Procter & Gamble, Siemens and Veolia.

“The second Global Cleantech 100 shines a spotlight on which companies and which technology areas the global innovation community is currently most excited about, from a commercial standpoint,” said Richard Youngman, MD, Europe & VP, Global Research at Cleantech Group. “There have been significant changes since 2009: more Asian companies and less renewable energy generation companies attest to the growing diversification of cleantech innovation. Cleantech is a broader phenomenon than just clean energy. The wider issues of resource scarcity are starting to gain attention and traction.”

“The Global Cleantech 100 list represents the most rigorous, serious attempt made yet to provide a scorecard of the progress that is being made by cleantech companies. This year’s expert panel involved a greater level of corporate participation than last year’s, and we also saw an increased presence of companies from China in the Top 100 list – both trends that we at VantagePoint see as critical signs of the times,” commented Stephan Dolezalek, the Cleantech Group Leader at VantagePoint Venture Partners. VantagePoint, for the second year in a row, had more investee companies in the 100 than any other investor.

“We are proud to be named among the Global Cleantech 100 for the second straight year, honoring our achievements in commercializing the next generation of reverse osmosis membranes,” said Jeff Green, CEO of NanoH2O. “Our nanocomposite reverse osmosis membranes represent an important step toward improving the economics of desalination, and this recognition is a great validation of the future impact our technology will have on increasing global fresh water supply.”

Source: http://www.nanoh2o.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.